| Classical mathematical models for description and prediction of experimental tumor growth S Benzekry, C Lamont, A Beheshti, A Tracz, JML Ebos, L Hlatky, ... PLoS Comput Biol 10 (8), e1003800, 2014 | 346 | 2014 |
| Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy R Serre, S Benzekry, L Padovani, C Meille, N André, J Ciccolini, F Barlesi, ... Cancer research 76 (17), 4931-4940, 2016 | 91 | 2016 |
| Modeling spontaneous metastasis following surgery: an in vivo-in silico approach S Benzekry, A Tracz, M Mastri, R Corbelli, D Barbolosi, JML Ebos Cancer research 76 (3), 535-547, 2016 | 62 | 2016 |
| Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine S Benzekry, E Pasquier, D Barbolosi, B Lacarelle, F Barlési, N André, ... Seminars in Cancer Biology 35, 53-61, 2015 | 58 | 2015 |
| Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers S Benzekry, P Hahnfeldt Journal of theoretical biology 335, 235-244, 2013 | 40 | 2013 |
| Global dormancy of metastases due to systemic inhibition of angiogenesis S Benzekry, A Gandolfi, P Hahnfeldt PloS one 9 (1), e84249, 2014 | 39 | 2014 |
| A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology S Benzekry, G Chapuisat, J Ciccolini, A Erlinger, F Hubert Comptes Rendus Mathematique 350 (1-2), 23-28, 2012 | 38 | 2012 |
| Modeling the impact of anticancer agents on metastatic spreading S Benzekry, N André, A Benabdallah, J Ciccolini, C Faivre, F Hubert, ... Mathematical Modelling of Natural Phenomena 7 (1), 306-336, 2012 | 36 | 2012 |
| Computational modelling of metastasis development in renal cell carcinoma E Baratchart, S Benzekry, A Bikfalvi, T Colin, LS Cooley, R Pineau, ... PLoS computational biology 11 (11), e1004626, 2015 | 33 | 2015 |
| Mathematical modeling of tumor–tumor distant interactions supports a systemic control of tumor growth S Benzekry, C Lamont, D Barbolosi, L Hlatky, P Hahnfeldt Cancer research 77 (18), 5183-5193, 2017 | 29 | 2017 |
| Host age is a systemic regulator of gene expression impacting cancer progression A Beheshti, S Benzekry, JT McDonald, L Ma, M Peluso, P Hahnfeldt, ... Cancer research 75 (6), 1134-1143, 2015 | 28 | 2015 |
| Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis B Sébastien Journal of Evolution Equations 11 (1), 187-213, 2011 | 27 | 2011 |
| Model driven optimization of antiangiogenics+ cytotoxics combination: application to breast cancer mice treated with bevacizumab+ paclitaxel doublet leads to reduced tumor … S Mollard, J Ciccolini, DC Imbs, R El Cheikh, D Barbolosi, S Benzekry Oncotarget 8 (14), 23087, 2017 | 26 | 2017 |
| Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers S Benzekry ESAIM: Mathematical Modelling and Numerical Analysis-Modélisation …, 2012 | 26 | 2012 |
| Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice F Lignet, S Benzekry, S Wilson, F Billy, O Saut, M Tod, B You, AA Berkane, ... Journal of theoretical biology 320, 86-99, 2013 | 25 | 2013 |
| Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks S Benzekry, JA Tuszynski, EA Rietman, GL Klement Biology direct 10 (1), 1-14, 2015 | 20 | 2015 |
| Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology A Rodallec, S Benzekry, B Lacarelle, J Ciccolini, R Fanciullino Critical Reviews in Oncology/Hematology 129, 1-12, 2018 | 19 | 2018 |
| Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles A Rodallec, G Sicard, R Fanciullino, S Benzekry, B Lacarelle, G Milano, ... Expert opinion on drug metabolism & toxicology 14 (11), 1139-1147, 2018 | 17 | 2018 |
| Revisiting bevacizumab+ cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non‐small cell lung carcinoma DC Imbs, R El Cheikh, A Boyer, J Ciccolini, C Mascaux, B Lacarelle, ... CPT: pharmacometrics & systems pharmacology 7 (1), 42-50, 2018 | 15 | 2018 |
| In vivo bioluminescence tomography for monitoring breast tumor growth and metastatic spreading: comparative study and mathematical modeling S Mollard, R Fanciullino, S Giacometti, C Serdjebi, S Benzekry, J Ciccolini Scientific reports 6 (1), 1-10, 2016 | 15 | 2016 |
joseph ciccoliniAix Marseille Univ (AMU, SMARTc CRCM) and Assistance Publique Hôpitaux de Marseille (APHM)Adresse e-mail validée de univ-amu.fr
